Oligon

📍 Montreal, Canada👥 4 employees💰 Last funded Sep 2025
Biotechnology Research🌐 Oligon.com
Website LinkedIn
Oligon™ is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our proprietary SeekR™ platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex multigenic disease.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Oligon?
Oligon has 1 investors on record on gritt.io.
When did Oligon last raise funding?
The most recent investment in Oligon recorded on gritt.io was in September 2025.
What industry is Oligon in?
Oligon operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oligon based?
Oligon is headquartered in Montreal, Canada.